MedTrace Logo

A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver

NCT01471080 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2014-07-02

No results posted yet for this study

Summary

In the past, the investigators often treated giant cavernous hemangiomas of the liver by hepatectomy.Recently RFA and laparoscopic hepatectomy are also available and could be applied to cure this disease.But we can't get a clear answer about their effectiveness and safety. Hence the investigators conduct this study to explore the effectiveness and efficiency of the these two methods and compare their short to mid-term outcomes.

Conditions

  • Laparoscopic Hepatectomy
  • Radio-frequency Ablation
  • Giant Cavernous Hemangiomas
  • Liver

Interventions

PROCEDURE

RFA

using RFA to treat cavernous hemangiomas

PROCEDURE

hepatectomy

using hepatectomy to treat cavernous hemangiomas

Sponsors & Collaborators

  • Southwest Hospital, China

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-10-31
Completion
2014-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01471080 on ClinicalTrials.gov